Want to join the conversation?
$NKE expects it strong results momentum to continue into 4Q16 and beyond. For 4Q16 and FY16, $NKE expects reported revenue to grow at a mid single-digit rate. For gross margin, the company expects an expansion of about 50 BP for FY16 with 4Q16 GM flat to slightly expanding YoverY.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.